PharmaShots | Incisive News in 3 Shots

Subscribe Now

GenFleet

GenFleet Receives EMA Approval to Study GFH925 + Erbitux (cetuximab) as 1L Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer

GenFleet Receives EMA Approval to Study GFH925 + Erbitux (cetuximab) as 1L Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cance...

March 2, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us